NCCN Guidelines for Patients®

sarcoma

The National Comprehensive Cancer Network® (NCCN®) aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients®, translations of the NCCN clinical guidelines, are meant to help patients with cancer talk with their physicians about the best treatment options for their disease. NCCN Guidelines for Patients® do not replace the expertise and clinical judgment of the physician.

Clinical practice guidelines are decision tools that are created by doctors to explain a disease and determine the best way to treat a patient, depending on their diagnosis, disease stage, and other factors, such as age. These guidelines help doctors make decisions, by explaining the pros and cons of each option.

NCCN currently offers NCCN Guidelines for Patients for the following: Breast Cancer Stages 0-IV, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Caring for Adolescents and Young Adults (AYA); Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Lung Cancer Screening; and Soft Tissue Sarcoma.

Print versions are available for certain disease types as supplies last.

NCCN is committed to developing a comprehensive library with support from the NCCN Foundation®.

NCCN Guidelines for Patients® by Cancer Type